These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24977733)

  • 21. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
    Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
    Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional divergence of phospholipase A(2)-like protein cDNAs between New Guinean and Australian Pseudechis australis.
    Inagaki H; Yamauchi Y; Toriba M; Kubo T
    Toxicon; 2010 Sep; 56(4):637-9. PubMed ID: 20466013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulant effects of black snake (Pseudechis spp.) venoms and in vitro efficacy of commercial antivenom.
    Lane J; O'Leary MA; Isbister GK
    Toxicon; 2011 Sep; 58(3):239-46. PubMed ID: 21723878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
    Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies on the mass of venom injected by Elapid snakes.
    Morrison JJ; Pearn JH; Charles NT; Coulter AR
    Toxicon; 1983; 21(2):279-84. PubMed ID: 6857711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross reactivity between venomous, mildly venomous, and non-venomous snake venoms with the Commonwealth Serum Laboratories Venom Detection Kit.
    Jelinek GA; Tweed C; Lynch D; Celenza T; Bush B; Michalopoulos N
    Emerg Med Australas; 2004; 16(5-6):459-64. PubMed ID: 15537410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant.
    Favaloro EJ; Bonar R; Marsden K
    Semin Thromb Hemost; 2012 Jun; 38(4):404-11. PubMed ID: 22565408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL; Howard C
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study.
    Gouin-Thibault I; Flaujac C; Delavenne X; Quenet S; Horellou MH; Laporte S; Siguret V; Lecompte T
    Thromb Haemost; 2014 Feb; 111(2):240-8. PubMed ID: 24172843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of three APTT reagents in a routine laboratory: toward a compromise.
    Rozen L; Copette F; Noubouossie DF; Demulder A
    Clin Lab; 2013; 59(7-8):921-4. PubMed ID: 24133925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
    McGlasson DL; Fritsma GA
    Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARACHnase. An evaluation of a positive control for platelet neutralization procedure testing with seven commercial activated partial thromboplastin time reagents.
    McGlasson DL; Babcock JL; Berg L; Triplett DA
    Am J Clin Pathol; 1993 Nov; 100(5):576-8. PubMed ID: 8249897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
    Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes.
    O'Leary MA; Isbister GK; Schneider JJ; Brown SG; Currie BJ
    Toxicon; 2006 Jul; 48(1):4-11. PubMed ID: 16764898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents.
    Iorio A; Nucciarelli F; Renga C; Nenci GG; Gianese F; Agnelli G
    Haemostasis; 1997; 27(2):85-90. PubMed ID: 9212356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
    Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of a prolonged APTT. Different approaches taken by laboratories to achieve the same diagnosis.
    Jennings I; Kitchen DP; Kitchen S; Woods TA; Walker ID
    Int J Lab Hematol; 2013 Apr; 35(2):177-82. PubMed ID: 23113926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser.
    Solano C; Zerafa P; Bird R
    Int J Lab Hematol; 2011 Feb; 33(1):67-78. PubMed ID: 20649909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.